Barclays PLC Neuronetics, Inc. Transaction History

Barclays PLC

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$2.09 - $3.71 $8,466 - $15,029	-4,051 Reduced 97.73%	94 $0
Q1 2022 May 16, 2022	SELL	$2.84 - $4.52 $76,188 - $121,258	-26,827 Reduced 86.62%	4,145 $12,000
Q4 2021 Feb 14, 2022	BUY	$3.87 - $6.59 $79,501 - $135,378	20,543 Added 196.98%	30,972 $138,000
Q3 2021 Nov 09, 2021	BUY	$6.22 - $15.54 $45,219 - $112,975	7,270 Added 230.14%	10,429 $69,000
Q2 2021 Aug 13, 2021	SELL	$10.15 - $17.25 $19,680 - $33,447	-1,939 Reduced 38.03%	3,159 $51,000
Q1 2021 May 13, 2021	SELL	$10.6 - $21.27 $61,034 - $122,472	-5,758 Reduced 53.04%	5,098 $63,000
Q4 2020 Feb 11, 2021	SELL	$4.95 - $11.45 $58,028 - $134,228	-11,723 Reduced 51.92%	10,856 $121,000
Q3 2020 Nov 12, 2020	SELL	$1.82 - $5.87 $6,950 - $22,417	-3,819 Reduced 14.47%	22,579 $110,000
Q2 2020 Aug 12, 2020	BUY	$1.41 - $2.61 $30,933 - $57,260	21,939 Added 492.02%	26,398 $51,000
Q1 2020 May 13, 2020	SELL	$1.28 - $4.5 $11,493 - $40,405	-8,979 Reduced 66.82%	4,459 $9,000
Q4 2019 Feb 10, 2020	BUY	$4.03 - $9.22 $26,783 - $61,276	6,646 Added 97.85%	13,438 $60,000
Q3 2019 Nov 14, 2019	SELL	$8.31 - $13.03 $15,705 - $24,626	-1,890 Reduced 21.77%	6,792 $57,000
Q2 2019 Aug 14, 2019	BUY	$9.0 - $17.2 $22,887 - $43,739	2,543 Added 41.42%	8,682 $109,000
Q1 2019 May 15, 2019	BUY	$13.6 - $19.58 $65,810 - $94,747	4,839 Added 372.23%	6,139 $94,000
Q4 2018 Feb 14, 2019	SELL	$16.0 - $31.84 $17,456 - $34,737	-1,091 Reduced 45.63%	1,300 $25,000
Q3 2018 Nov 14, 2018	BUY	$24.32 - $37.54 $58,149 - $89,758	2,391 New	2,391 $77,000

10M

24.1K

200

Ticker STIM
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 27,022,800
Market Cap $125M
Description
Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive diso...

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

Stay updated on Barclays PLC with notifications on news.